Home・Stock List・Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals Inc

Closed

SectorHealthcare

541.53 0.12

Buy Sell

Overview

Share price change

24h

Current

Min

539.38

Max

543.66

Key metrics
By Trading Economics
Income	-36M -94M
Sales	-9.7M 311M
EPS	-1.38
Profit margin	-30.318
Employees	915
EBITDA	-36M -86M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+26.82% upside

Dividends
By Acuity
Next Earnings	30 Jul 2026

Market Stats
By TradingEconomics
Market Cap	393M 12B
Previous open	541.41
Previous close	541.53

News Sentiment

By Acuity

46%

54%

140 / 340 Healthcare

Madrigal Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

20 Jul 2026, 16:02 UTC

Social Media

Madrigal Pharmaceuticals is lower today amid aggressive call buying and heightened market volume, with broader inflation concerns influenced by geopolitical tensions.

Peer Comparison

Price change

Madrigal Pharmaceuticals Inc Forecast

Price Target

By TipRanks

26.82% upside

12 Months Forecast

Average 690.55 USD 26.82%

High 964 USD

Low 553 USD

Based on 12 Wall Street analysts offering 12 month price targets forMadrigal Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

Buy

Hold

Sell

Based on 12 analysts giving stock ratings to Madrigal Pharmaceuticals Inc - Dist in the past 3 months.

Sentiment

By Acuity

140 / 340 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Madrigal Pharmaceuticals Inc

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed thyroid hormone receptor beta agonist, which is in Phase 3 clinical trials for treating NASH. The company is headquartered in West Conshohocken, Pennsylvania.